Population pharmacokinetics of enterally administered cisapride in young infants with gastro-oesophageal reflux disease

British Journal of Clinical Pharmacology

Volumn 48, Issue 5, 1999, Pages 688-693

  Preechagoon, Y ^a   Charles, B ^a   Piotrovskij, V ^b   Donovan, T ^c   Van Peer, A ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Cisapride; Infants; NONMEM; Population pharmacokinetics; Reflux disease

Indexed keywords

ANTIEMETIC AGENT; CISAPRIDE;

ARTICLE; COMPARTMENT MODEL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; BAYES THEOREM; CISAPRIDE; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; HALF-LIFE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MODELS, BIOLOGICAL; POPULATION;

EID: 0032735651     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00068.x     Document Type: Article

References (22)

1. 1 Herbst JJ. Gastroesophageal reflux. J Pediatr 1981; 98: 859-870.
2. 2 Weinhrauch TR. Gastroesophageal reflux: Pathogenesis and clinical implications. Eur J Pediatr 1985; 144: 215-218.
3. 3 Cucchiara S, Staiano A, Boccieri A, et al. Effects of cisapride on parameter of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease. Gut 1990; 31: 21-25.
4. 4 Newell SJ. Cisapride: its use in children. Br J Hosp Med 1990; 44: 408-409.
5. 5 Vandenplas Y, Deneyer M, Verlinden M, Aerts T, Sacre L. Gastroesophageal reflux incidence and respiratory dysfunction during sleep in infants: Treatment with cisapride. J Pediatr Gastroenterol Nutr 1989; 8: 31-36.
6. 6 Malfroot A, Vandenplas Y, Verlinden M, Piepsz A, Dab I. Gastroesophageal reflux and unexplained chronic respiratory disease in infants and children. Pediatr Pulmonol 1987; 3: 208-213.
7. 7 Olafsdottir E. Gastro-oesophageal reflux and chronic respiratory disease in infants and children: Treatment with cisapride. Scand J Gastroenterol 1995; 30(Suppl 211): 32-34.
8. 8 Wiseman LR, Faulds D. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 1994; 47: 116-152.
9. 9 McCallum RW, Prakash C, Campoli-Richards DM, Goa KL. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs 1988; 36: 652-681.
10. 10 Kearns GL, Reed MD. Clinical pharmacokinetics in infants and children: a reappraisal. Clin Pharmacokinet 1989; 17(Suppl 1): 29-67.
11. 11 Morselli PL, Franco-Morselli R, Bossi L. Clinical pharmacokinetics in newborns and infants: age-related differences and therapeutic implications. Clin Pharmacokinet 1980; 5: 485-527.
12. 12 Pillans PI, Wood SM. Cisapride increases micturition frequency. J Clin Gastroenterol 1994; 19: 336-346.
13. 13 Boyd IW, Rohan AP. Urinary disorders associated with cisapride. Med J Aust 1994; 160: 579-580.
14. 14 Lewin MB, Bryant RM, Fenrich AL, Grifka RG. Cisapride-induced long QT interval. J Pediatr 1996; 128: 279-281.
15. 15 Prober C. Potential of population pharmacokinetics to reduce the frequency of blood sampling required for estimating kinetic parameters in neonates. Dev Pharmacol Ther 1992; 18: 71-80.
16. 16 Preechagoon Y, Charles BG. Analysis of cisapride in neonatal plasma using high-performance liquid chromatography with a base-stable column and fluorescence detection. J Chromatogr B 1995; 670: 139-143.
17. 17 Boeckmann AJ, Sheiner LB, Beal SL, eds. NONMEM Users Guides NONMEM Project Group, University of California at San Francisco 1992.
18. 18 Van Peer A, Verlinden M, Woestenborghs R, Meuldermans W, Heykants J, Reyntjens A. Clinical pharmacokinetics of cisapride. In Progress in the Treatment of Gastrointestinal Motility Disorders: the Role of Cisapride, eds Johnson, Lux. Amsterdam: Excerpta Medica 1988; 23-29.
19. 19 Venables WN, Ripley BD. Modern Applied Statistics with S-Plus Springer-Verlag. NY, 1994; p. 203.
20. 20 Woestenborghs R, Lorreyne W, Van Rompaey F, Heykants J. Determination of cisapride in plasma and animal tissues by high-performance liquid chromatography. J Chromatogr 1988; 424: 195-200.
21. 21 Guyon G. Pharmacokinetic considerations in neonatal drug therapy. Neonatal Network 1989; 7: 9-12.
22. 22 Melis K, Janssens G. Long-term use of cisapride (Prepulsid) in premature neonates. Acta Gastroenterol Belg 1990; 53: 372-375.